BRD7 has been shown to act as a transcriptional regulator 20-22, therefore, we conducted ChIP-seq analysis to characterize genome-wide BRD7 binding sites using BRD7-overexpressing HCC cells (HepG2 and Bel7402). Here, BRD7 is linked to hepatocellular carcinoma.